Persistent renin-angiotensin system activation after anti-reflux surgery and its management

Minu Bajpai1, C S Bal, Rakesh Kumar

  • 1Department of Paediatric Surgery, All India Institute of Medical Sciences, New Delhi 110029, India. bajpai2@hotmail.com

Insights

Anti-reflux surgery initially improves kidney function by down-regulating the renin-angiotensin system. However, this effect wanes over time, but angiotensin-converting enzyme inhibitors (ACE-I) can aid renal recovery.

Area of Science:

  • Pediatric Nephrology
  • Urology

Background:

  • Vesicoureteral reflux (VUR) in children can lead to renal scarring and dysfunction.
  • The renin-angiotensin system (RAS) plays a role in renal hemodynamics and function.
  • Anti-reflux surgery is a common treatment for high-grade VUR.

Purpose of the Study:

  • To investigate the activation of the renin-angiotensin system (RAS) following anti-reflux surgery in children.
  • To evaluate the efficacy of angiotensin-converting enzyme inhibitors (ACE-I) in improving renal function post-surgery.

Main Methods:

  • Thirty-nine children with high-grade primary VUR underwent anti-reflux surgery.
  • Postoperative monitoring included plasma renin activity (PRA), urinary microalbumin, renal scars, split renal function (SRF), glomerular filtration rate (GFR), serum creatinine, blood pressure, and urinary tract infections.
  • Patients were assessed in early and late postoperative phases, and before and after ACE-I therapy.

Main Results:

  • Early postoperative period showed improvement in renal parameters (SRF, GFR) and a significant decrease in PRA.
  • These improvements were not sustained in the late postoperative phase, with a notable rise in PRA.
  • Following ACE-I therapy, there was a modest improvement in SRF and GFR, and a significant reduction in urinary microalbumin.

Conclusions:

  • The beneficial effects of anti-reflux surgery on RAS activation and renal function are temporary.
  • Long-term follow-up is necessary to monitor renal parameters after anti-reflux surgery.
  • Angiotensin-converting enzyme inhibitors (ACE-I) demonstrate a role in aiding renal recovery in children post anti-reflux surgery.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...